Publicaciones en las que colabora con Ana Patiño García (15)

2018

  1. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma

    Cancer Letters, Vol. 430, pp. 193-200

2017

  1. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells

    Cancer Letters, Vol. 388, pp. 262-268

2015

  1. Antitumoral-Lipid-Based nanoparticles: A platform for future application in osteosarcoma therapy

    Current Pharmaceutical Design, Vol. 21, Núm. 42, pp. 6104-6124

  2. Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population

    Clinical Nutrition, Vol. 34, Núm. 4, pp. 694-699

  3. Lipid nanoparticles enhance the efficacy of chemotherapy in primary and metastatic human osteosarcoma cells

    Journal of Drug Delivery Science and Technology, Vol. 30, pp. 435-442

2014

  1. Sugar-sweetened carbonated beverage consumption and childhood/adolescent obesity: A case-control study

    Public Health Nutrition, Vol. 17, Núm. 10, pp. 2185-2193

2007

  1. A novel mutation Thr162Arg of the melanocortin 4 receptor gene in a Spanish children and adolescent population

    Clinical Endocrinology, Vol. 66, Núm. 5, pp. 652-658

2006

  1. Influencia del polimorfismo -866 G/A del gen de la UCP2 en población infantil obesa

    Nutricion Hospitalaria

2005

  1. No evidence of association between the serotonin 2A receptor -1438G/A promoter polymorphism and childhood obesity in a Spanish population: A case-parent study and a matched case-control study

    Nutritional Neuroscience, Vol. 8, Núm. 4, pp. 207-211

  2. Pediatric meningosarcoma: Clinical evolution and genetic instability

    Pediatric Neurology, Vol. 32, Núm. 5, pp. 352-354

2004

  1. Gene–gene interaction between PPARγ2 and ADRβ3 increases obesity risk in children and adolescents

    International Journal of Obesity, Vol. 28, pp. S37-S41

  2. Influence of two polymorphisms of the tumoral necrosis factor-α gene on the obesity phenotype

    Diabetes, Nutrition and Metabolism - Clinical and Experimental, Vol. 17, Núm. 1, pp. 17-22

  3. Polimorfismos genéticos en TNFalfa y PPARgamma2 y síndrome de resistencia a insulina

    Acta Diabetológica, Vol. 20, Núm. 1, pp. 33-40

2000

  1. Characteristics and value of chromosome aberrations induced by antitumor treatments in pediatric patients with cancer

    Revista de medicina de la Universidad de Navarra, Vol. 44, Núm. 1, pp. 15-24

  2. Nonclonal chromosomal aberrations induced by anti-tumoral regimens in childhood cancer: Relationship with cancer-related genes and fragile sites

    Cancer Genetics and Cytogenetics, Vol. 121, Núm. 1, pp. 78-85